Impact fact

Anne leverages her 20+ years of healthcare and life sciences industry experience to lead medtech strategy and portfolio development at ZS.


Anne is a principal in ZS’s New York office and heads the medtech strategy and portfolio business.


Anne joined ZS in January 2021, after a long career that spans the broader healthcare ecosystem from life sciences and the medtech industry to the hospital/provider side and healthcare delivery and access.


At ZS, Anne leads the strategy and portfolio development business in medtech, working with Fortune 500 companies and investors to drive growth and value creation. She is an expert in developing growth strategies that unlock the future value of innovations and enable companies to meet their business objectives. 


Over the years, Anne has supported many companies on a range of complex business issues, including portfolio strategy and management, market opportunity and forecasting, market access, and market entry into the U.S., Europe, Japan, and various emerging markets. She has also advised countless investors on diligences and mergers and acquisitions, which have led to successful global transactions.


Her expertise spans the medtech industry, with heavier emphasis on high-value capital equipment, surgical/interventional devices, and diagnostics and monitoring technologies. Anne is frequently asked to present at industry conferences as a thought leader and future-thinker on value-based growth strategies, specifically how to develop transformational strategies that align with stakeholder and customer needs to maximize the value of new technologies.

Prior experience

Prior to ZS, Anne built and led medtech strategy consulting practices at Huron Consulting Group and ClearView Healthcare Partners, and was a managing director and member of the life sciences leadership team at Navigant (formerly Easton Associates). She spent several years in hospital administration within academic medical centers, managing the neurosurgery division at the University of Chicago and the pulmonary and critical care medicine division at NYU. She began her career in industry at Vertex Pharmaceuticals as part of the original strategy and R&D planning group.


Anne holds an MBA from the Kellogg School of Management at Northwestern University, and earned a B.A. in neuroscience from Bowdoin College.